Immunotherapy and Biomarkers in Neurodegenerative Disorders

  • Martin Ingelsson
  • Lars Lannfelt

Part of the Methods in Pharmacology and Toxicology book series (MIPT)

Table of contents

  1. Front Matter
    Pages i-x
  2. Immunotherapy Against Amyloid-β in Alzheimer’s Disease

  3. Immunotherapy in Other Neurodegenerative Disorders

    1. Front Matter
      Pages 61-61
    2. Elvira Valera, Eliezer Masliah
      Pages 63-72
    3. Jun Sung Lee, Seung-Jae Lee
      Pages 73-83
    4. Achim Schneeberger, Suzanne Hendrix, Markus Mandler
      Pages 85-108
    5. Einar M. Sigurdsson
      Pages 109-120
    6. Kiran Yanamandra, Marc I. Diamond, David M. Holtzman
      Pages 121-138
  4. Biomarkers for Neurodegenerative Disorders

    1. Front Matter
      Pages 151-151
    2. Henrik Zetterberg, Jonathan M. Schott
      Pages 153-179
    3. Eric Westman, Lena Cavalin, Lars-Olof Wahlund
      Pages 181-198
    4. Joakim Bergström, Martin Ingelsson
      Pages 215-234
    5. Johan Wikström, Torsten Danfors
      Pages 235-252
    6. Sravani Musunuri, Ganna Shevchenko, Jonas Bergquist
      Pages 253-282
  5. Back Matter
    Pages 283-289

About this book


This practical volume examines a number of topics that explore the current status of immunotherapy and diagnostic markers for neurodegenerative disorders. With a focus on Alzheimer’s disease, the first sections of the book examine immunotherapeutic approaches for the aforementioned disease as well as for Parkinson’s disease and Huntington’s disease, amongst others. The last section of the book covers the importance of biomarker techniques to catch these diseases early enough for the treatments to be most useful. Written for the Methods in Pharmacology and Toxicology series, this book contains the kind of detailed descriptions and implementation advice that will offer a smooth transition into the lab. 

Authoritative and useful, Immunotherapy and Biomarkers in Neurodegenerative Disorders aims to aid in the continued progress in the development of novel immune-based drugs and diagnostic tools for these devastating brain diseases.


Amyloid-Beta Alzheimer’s Disease Αlpha-Synuclein Tau protein Therapeutic antibodies Monoclonal antibodies Immunotherapeutic targets Parkinson’s disease

Editors and affiliations

  • Martin Ingelsson
    • 1
  • Lars Lannfelt
    • 2
  1. 1.Dept Public Health & Caring Sci GerUppsala UniversityUppsalaSweden
  2. 2.Dept Public Health & Caring Sci GerUppsala UniversityUppsalaSweden

Bibliographic information

  • DOI
  • Copyright Information Springer Science+Business Media New York 2016
  • Publisher Name Humana Press, New York, NY
  • eBook Packages Springer Protocols
  • Print ISBN 978-1-4939-3558-1
  • Online ISBN 978-1-4939-3560-4
  • Series Print ISSN 1557-2153
  • Series Online ISSN 1940-6053
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Pharmacology & Toxicology
Consumer Packaged Goods